Literature DB >> 24985372

[The incidence differences among sex, geographical areas and mean age of diagnosis for liver cancer in China, 1989-2008].

Siwei Zhang1, Rongshou Zheng1, Hongmei Zeng1, Wanqing Chen2.   

Abstract

OBJECTIVE: Using the incidence data from 1989 to 2008 of liver cancer from population in cancer registration areas in China, the differences and changes of gender, urban and rural areas for liver cancer incidence in different years were studied, and the mean age of incidence was analyzed.
METHODS: The incidence data of liver cancer from National Cancer Registration database were sorted and checked. A total of 181 097 new liver cancer cases were collected, covering 711 843 051 person years from 1989 to 2008.Using Poisson regression model, Stratified by gender and areas, changes of incidence gender ratio, ratio of urban and rural, and mean age were analyzed.
RESULTS: After adjusting the age, the liver cancer incidence in male was about 3 times higher than that in females (ranging from 2.64-3.54), and the ratio change between male and female for the 20 years did not have statistically significant (P = 0.150). The incidence ratio between urban and rural areas has increased from 0.51 in 1989 to 0.61 in 2008 (P < 0.01). The mean ages of diagnosis for male and female increased from 57.14 years to 60.34 years, 61.69 years to 66.47 years, respectively from 1989 to 2008. The mean age of liver cancer diagnosis has increased in the 20 years (P < 0.01).
CONCLUSION: The liver cancer incidence between male and female did not change significantly among 20 years. The difference of liver cancer incidence between urban and rural areas has reduced, and the mean age of diagnosis was deferred.

Entities:  

Mesh:

Year:  2014        PMID: 24985372

Source DB:  PubMed          Journal:  Zhonghua Yu Fang Yi Xue Za Zhi        ISSN: 0253-9624


  6 in total

1.  Association of p53 codon 72 polymorphism with susceptibility to hepatocellular carcinoma in a Chinese population from northeast Sichuan.

Authors:  Jiajing Cai; Yan Cai; Qiang Ma; Fan Chang; Lei Xu; Guoyuan Zhang; Xiaolan Guo
Journal:  Biomed Rep       Date:  2017-01-11

2.  Prognostic gene biomarker identification in liver cancer by data mining.

Authors:  Gang Liu; Haitao Tang; Chen Li; Haiyan Zhen; Zhigang Zhang; Yongzhong Sha
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

3.  Prognostic value of the expression of cancer stem cell-related markers CD133 and CD44 in hepatocellular carcinoma: From patients to patient-derived tumor xenograft models.

Authors:  Qihong Zhao; Heng Zhou; Qifei Liu; Ye Cao; Gang Wang; Anla Hu; Liang Ruan; Sufang Wang; Qingli Bo; Wenjun Chen; Chuanlai Hu; Dexiang Xu; Fangbiao Tao; Jiyu Cao; Yongsheng Ge; Zongfan Yu; Li Li; Hua Wang
Journal:  Oncotarget       Date:  2016-07-26

4.  Disease burden of liver cancer in China from 1997 to 2016: an observational study based on the Global Burden of Diseases.

Authors:  Cheng Ding; Xiaofang Fu; Yuqing Zhou; Xiaoxiao Liu; Jie Wu; Chenyang Huang; Min Deng; Yiping Li; Lanjuan Li; Shigui Yang
Journal:  BMJ Open       Date:  2019-04-23       Impact factor: 2.692

5.  The Age-Specific Features and Clinical Significance of NRF2 and MAPK10 Expression in HCC Patients.

Authors:  Manar Atyah; Chenhao Zhou; Qiang Zhou; Wanyong Chen; Jialei Weng; Pengcheng Wang; Yi Shi; Qiongzhu Dong; Ning Ren
Journal:  Int J Gen Med       Date:  2022-01-20

6.  A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma.

Authors:  Xingchen Li; Xinyu Bi; Jianjun Zhao; Zhiyu Li; Jianguo Zhou; Zhen Huang; Yefan Zhang; Hong Zhao; Jianqiang Cai
Journal:  Transl Cancer Res       Date:  2021-04       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.